# Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/treatment-for-heart-failure-endpoints-for-drug-development-guidance-for-industry/3a3c4b6b-8dd2-4027-b7e6-10f7059fe28b

> FDA guidance document: Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry. Issue date: June 28, 2019. Get complete insights and analysis.

---

## Details

- Title: Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-06-28
- Comment Close Date: 2019-08-27
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-2314">FDA-2019-D-2314</a>

## Related Documents

- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Postapproval Pregnancy Safety Studies Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/postapproval-pregnancy-safety-studies-guidance-for-industry/3681b74c-6d89-4847-9151-7f24bcf1a63c)
- [Fabry Disease: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/fabry-disease-developing-drugs-for-treatment-guidance-for-industry/37d2e0fe-939f-490c-8fec-d2753a0f2f8c)